Movement Alert|CSOP SK Hynix Daily Max (2x) Leveraged Product Rises 5.99% in Regular Trading, SK Hynix Dual-Line Expansion Plan Boosts Market Sentiment

Market Focus
Sep 04

On September 4, CSOP SK Hynix Daily Max (2x) Leveraged Product rose 5.99% in regular trading, trading at 35.26 HKD/share, with turnover of HKD 127 million. The rebound follows two consecutive trading sessions of cumulative decline exceeding 10%.

On the news front, SK Hynix is reportedly exploring a plan to advance investments in its Yongin semiconductor cluster and Gwangju production base in parallel, intensifying capital deployment in its southwestern Gwangju facility. The company is evaluating whether to redirect equipment originally earmarked for the new Yongin factory to Gwangju or place additional new equipment orders for the site. For Yongin, the first phase cleanroom at the new factory targets activation by February next year, while Gwangju is expected to begin site preparation and basic construction next year, with the first wafer fab completion targeted for 2029.

The product had been under pressure earlier this week amid global bond market selloffs, rising rate expectations, and broker downgrades citing Samsung Electronics' improving HBM4 yield rates narrowing SK Hynix's competitive moat. The dual-line expansion news appeared to trigger a recovery in sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10